ATLAS: A phase 2, open-label study of rucaparib in patients with locally advanced or metastatic urothelial carcinoma

Autor:	Petros Grivas, Andrew Simmons, Simon Chowdhury, Susan Feyerabend, Yousef Zakharia, Sandy Srinivas, Debra H. Josephs, Sumati Gupta, Alejo Rodriguez-Vida, Daleen Thomas, Kenton Wride, Y. Loriot, Dale L. Nepert, Rachel L. Dusek, Andrea Necchi
Rok vydání:	2019
Předmět:	medicine.medical_specialty Metastatic Urothelial Carcinoma business.industry Urology Locally advanced chemistry.chemical_compound medicine.anatomical_structure chemistry Open label study Atlas (anatomy) Medicine In patient Radiology business Rucaparib
Zdroj:	European Urology Supplements. 18:e1838-e1839
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(19)31331-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f5bf0d8907c9709525f2d7909af9972b https://doi.org/10.1016/s1569-9056(19)31331-4 Zobrazit plný text záznamu Full Text from ScienceDirect